We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
-0.91%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$128M
AUM Growth
-$21.3M
(-14%)
Cap. Flow
-$12.5M
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
52.36%
Holding
99
New
13
Increased
31
Reduced
37
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$1.22M |
| 2 |
Intuitive Surgical
ISRG
|
+$1.22M |
| 3 |
Tenet Healthcare
THC
|
+$1.19M |
| 4 |
RadNet
RDNT
|
+$1.18M |
| 5 |
CVRx
CVRX
|
+$967K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.6M |
| 2 |
Gilead Sciences
GILD
|
+$1.99M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.43M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$1.34M |
| 5 |
Health Catalyst
HCAT
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Moderna
MRNA
$22B
| $159K | 0.12% |
5,600
+1,250
| +29% | +$44.4K |
|
77
Axsome Therapeutics
AXSM
$10.9B
| $119K | 0.09% |
1,020
+200
| +24% | +$22.8K |
|
78
Oric Pharmaceuticals
ORIC
$1.1B
| $112K | 0.09% |
+20,000
| New | +$175K |
|
|
TEM
79
Tempus AI
TEM
$8.31B
| $104K | 0.08% |
+2,160
| New | +$117K |
|
|
IOBT
80
DELISTED
IO Biotech
IOBT
| $104K | 0.08% |
95,000
+20,000
| +27% | +$18.9K |
|
81
Arvinas
ARVN
$520M
| $90.8K | 0.07% |
12,930
-17,220
| -57% | -$270K |
|
82
CRISPR Therapeutics
CRSP
$4.88B
| $86.4K | 0.07% |
+2,540
| New | +$108K |
|
83
Recursion Pharmaceuticals
RXRX
$1.69B
| $60.8K | 0.05% |
+11,500
| New | +$83.8K |
|
84
enGene Therapeutics
ENGN
$119M
| $52.4K | 0.04% |
11,700
-67,219
| -85% | -$417K |
|
85
Cigna
CI
$74.5B
| – | – |
-2,250
| Closed | -$621K |
|
|
CRGX
86
DELISTED
CARGO Therapeutics
CRGX
| – | – |
-8,500
| Closed | -$123K |
|
87
CVS Health
CVS
$134B
| – | – |
-22,000
| Closed | -$988K |
|
88
Edwards Lifesciences
EW
$51.1B
| – | – |
-7,850
| Closed | -$581K |
|
89
Exelixis
EXEL
$13.8B
| – | – |
-3,500
| Closed | -$117K |
|
90
Geron
GERN
$821M
| – | – |
-63,500
| Closed | -$225K |
|
|
91
Health Catalyst
HCAT
$163M
| – | – |
-160,000
| Closed | -$1.13M |
|
92
Humana
HUM
$45B
| – | – |
-1,581
| Closed | -$401K |
|
93
Iovance Biotherapeutics
IOVA
$1.93B
| – | – |
-81,500
| Closed | -$603K |
|
94
Olema Pharmaceuticals
OLMA
$985M
| – | – |
-61,650
| Closed | -$359K |
|
95
Privia Health
PRVA
$3B
| – | – |
-52,000
| Closed | -$1.02M |
|
|
96
Sarepta Therapeutics
SRPT
$1.68B
| – | – |
-11,020
| Closed | -$1.34M |
|
|
TSBX
97
DELISTED
Turnstone Biologics
TSBX
| – | – |
-517,648
| Closed | -$257K |
|
|
ITCI
98
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-4,900
| Closed | -$409K |
|
|
NARI
99
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-15,153
| Closed | -$774K |
|
Similar funds
RIP
LFWA
CF
WIM
MW
AFC
TGM
BIS
Sectoral Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Sectoral Asset Management held 99 positions worth $128M, down 14% from $150M the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Sectoral Asset Management withdrew a net $12.5M in Q1 2025, closing 15 positions and reducing 37 holdings. Its most notable exit was Sarepta Therapeutics, an estimated $1.34M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 99% a quarter earlier.
Against the trend, Sectoral Asset Management opened a new position in DexCom worth $1.02M.
- Sectoral Asset Management's largest Q1 2025 buy was DexCom: 15,000 shares worth $1.02M.
- Sectoral Asset Management added most to Intuitive Surgical in Q1 2025, an estimated $1.22M increase.
- Sectoral Asset Management's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $2.6M.
- Sectoral Asset Management fully exited Sarepta Therapeutics in Q1 2025, selling an estimated $1.34M.
- Sectoral Asset Management's ten largest holdings make up 52% of its $128M portfolio in Q1 2025.
- Sectoral Asset Management opened 13 new positions and closed 15 in Q1 2025.
- Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $128M.
Based on Sectoral Asset Management's 13F filing for Q1 2025, filed 15 May 2025.